Arvind P. Pathak1, Yoshinori Kato1,
Nicole Benoit1
1JHU ICMIC Program, Russel H. Morgan
Dept. of Radiology and Radiological Science, The
Here
we describe the development of dual contrast lectinized liposomes that
improve our ability to image the structural and functional changes in tumor
blood vessels using MRI and optical imaging. Limitations of conventional
contrast-enhanced in vivo MRI include low spatial resolution because of
relatively short circulation half-life of such agents, and loss of contrast
due to extravasation from permeable tumor vessels. We developed a blood
vessel-specific nanoparticle targeted to Bandeiraea Simplicifolia lectin, a
carbohydrate-binding protein that binds to α-D-galactosyl residues on
endothelial cells. MRI and optical imaging demonstrate that multi-modal,
targeted liposomes greatly enhance our ability to characterize tumor
angiogenesis.